Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


Helix Biopharma to Present L-DOS47 Lung Cancer Research Findings at the Fourth International Conference on Tumor Microenvironment in Florence, Italy

- Helix BioPharma Corp. (TSX: HBP /Frankfurt: WKN918864) AURORA, ON, March 5 /CNW/Dr. Heman Chao, Vice President of Researchat Helix BioPharma Corp., a developer of novel cancer therapeutics,will be presenting a scientific poster at the Fourth InternationalConference on Tumor Microenvironment, which runs from March 6th to10th in Florence, Italy. The conference, hosted by the...

Replidyne Phase II Pediatric Trial Meets Primary Objective

LOUISVILLE, Colo., March 06, 2007 /PRNewswire-FirstCall/ --Replidyne, Inc. announced today that it has completed its Phase IIclinical trial using faropenem medoxomil (faropenem) in pediatricpatients with acute otitis media (AOM), a common infection of themiddle ear. Initial analyses of the study results show that it metits primary objective to show that faropenem was effective ineradicatin...

DVT Awareness Survey Findings: Heart and Respiratory Patients

WASHINGTON, March 06, 2007 /PRNewswire/ -- Up to two millionAmericans are affected each year by DVT, with up to 600,000hospitalized. Its primary complication, pulmonary embolism (PE),claims up to 300,000 lives annually -- more than breast cancer andAIDS combined. People who suffer from cardiovascular disease may beat increased risk for DVT, because these factors also heighten thelikelihood...

Pozen Announces Positive Outcome for PA 325

Chapel Hill, N.C., March 6, 2007-Pozen Inc. (NASDAQ: POZN),today announced top-line results of its "Safer Aspirin" PA 325proof-of-concept study conducted during the fourth quarter of 2006.PA 325 is a patented formulation of 325mg of aspirin surrounded bya 20mg coating of an immediate release formulation of a proton pumpinhibitor. The PA 325, 28 day study, involved two groups of 40 subject...

Advanced Magnetics Announces Presentation of Ferumoxytol Data at the National Kidney Foundation 2007 Spring Clinical Meetings

CAMBRIDGE, Mass., March 06, 2007 /PRNewswire-FirstCall/ --Advanced Magnetics today announced that data from three completedPhase III multi- center clinical studies of ferumoxytol as anintravenous iron replacement therapeutic will be presented duringthe National Kidney Foundation (NKF) 2007 Spring Clinical Meetingstaking place April 10th through 14th in Orlando, Florida. Twoposters containi...

POZEN Announces Positive Outcome for PA 325 Proof of Concept Study

CHAPEL HILL, N.C.--(BUSINESS WIRE)--Mar 6, 2007 - POZEN Inc.(NASDAQ: POZN), today announced top-line results of its "SaferAspirin" PA 325 proof-of-concept study conducted during the fourthquarter of 2006. PA 325 is a patented formulation of 325mg ofaspirin surrounded by a 20mg coating of an immediate releaseformulation of a proton pump inhibitor. The PA 325, 28 day study, involved two group...

Nventa Announces Presentation of Positive HspE7 Data from NCI-Sponsored Clinical Trial in Cervical Dysplasia

- 78 Percent of Patients Showed Complete Response or Reduction ofLesion Size by More than Fifty Percent - SAN DIEGO, CA, March 05, 2007 /PRNewswire-FirstCall/ - NventaBiopharmaceuticals Corporation today announced the presentation ofpositive results from a clinical trial examining the safety andefficacy of pilot process HspE7, an investigational therapeuticvaccine for human papillomavirus (...

AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II Study with Novel Cystic Fibrosis Therapy

VIENNA, Austria and CHAPEL HILL, N.C., US, March 06, 2007/PRNewswire/ -- AOP Orphan Pharmaceuticals AG ("AOP Orphan") andLantibio, Inc. ("Lantibio") today announced positive final resultsfrom their placebo controlled, double-blinded Phase II clinicalstudy of Moli1901, an experimental compound to treat cysticfibrosis ("CF"). Moli1901 is being developed by AOP Orphan inEurope under a licensi...

Advanced Cell Technology's Ability to Rescue Vision in Blind Rats Noted in Scientific American

ALAMEDA, Calif.--(BUSINESS WIRE)--Mar 5, 2007 - Advanced CellTechnology, Inc.'s (OTCBB: ACTC) ability to rescue vision in blindrats was noted in Scientific American's March 2007 issue as thelead story of its News Scan section. The full text of the article,which notes Advanced Cell's ability to "coax embryonic stem cellsto turn into transplantable retinal pigment epithelial (RPE)tissue," is...

Accentia Biopharmaceuticals Scientific Presentations Demonstrate Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at the Annual Meeting of the American Academy of Allergy, Asthma, and Immunology

TAMPA, Fla.--(BUSINESS WIRE)--Mar 7, 2007 - AccentiaBiopharmaceuticals, Inc. (NASDAQ: ABPI), presented three posters atthe Annual Meeting of the American Academy of Allergy, Asthma, andImmunology from February 23 - 27, 2007 in San Diego, CA. Theposters discussed findings from a survey of 202 otolaryngologists(ENTs) and allergists in the U.S., U.K., France, and Germany on theburden of chroni...
[next]
(Date:8/3/2020)... ... August 03, 2020 , ... WorkBook6 – a Tempe, Arizona-based ... The site provides a simple and efficient way for Americans over the age ... as an important expansion for the insurance marketing ecosystem, and a critical service ...
(Date:7/31/2020)... ... July 31, 2020 , ... ... plans, is announcing an expansion of clinical & technical capabilities to cover the ... most complete back and joint health solution. , Currently, employers interested in ...
(Date:7/22/2020)... CHICAGO (PRWEB) , ... July 22, 2020 , ... ... of 40 unique opioid related compositions of matter and manufacturing processes from Brock ... Market, auction lot 114 , sold by Brock University provides the manufacturing ...
(Date:7/18/2020)... ... July 17, 2020 , ... “Frozen.” It’s not simply the title of ... oftentimes for unknown reasons – resulting in stiffness, persistent pain and loss of range ... treating problems of the upper limbs and joints and founder and chief medical officer ...
(Date:7/18/2020)... N.Y. (PRWEB) , ... July 18, 2020 , ... When ... it created a huge opportunity for small and some bigger businesses to obtain a ... companies, and members of the “GIG Economy” do not realize they are eligible. ...
Breaking Medicine News(10 mins):
... consumption dropped, study found , FRIDAY, June 18 (HealthDay ... may reduce consumption and help lower levels of obesity ... suggests. , Researchers examined what happened during a time ... in Boston increased the price of regular soft drinks ...
... , ... Life sell an extensive range of vitamins supplements and nutritional supplements by top manufacturers ... ... Established in 1999, Vitamins for Life (vitaminsforlife.co.uk) supplies practitioner-grade nutritional supplements that ...
... 2010: Systemic Lupus Erythematosus (SLE) patients from Brazil ... that their rheumatic conditions negatively affect their emotional ... today at EULAR 2010, the Annual Congress of ... Furthermore, findings of the French study specifically revealed ...
... The effects of Systemic Lupus Erythematosus (SLE) may differ ... results of a new study presented today at EULAR ... Rheumatism in Rome, Italy. In particular, the study reinforced ... European subpopulations. Results from a Europe-wide study, involving ...
... Kids Bento ... , ... 18, 2010 -- School’s about to start and so is the mad morning scramble of ... kids’ bento boxes , from Laptop Lunches. They’re ideal for packing fun, wholesome, ...
... ... 360 Degree Guarantee and provide consumers with coverage that extends past the original manufacturer labor ... standard warranty. , ... 18, 2010 -- Treadmill Doctor has announced the introduction of their new 360 ...
Cached Medicine News:
ManuTrain is an active wrist support that has optional features for increased stabilization....
... Wrist Cryo/Cuff combines the therapeutic benefits of controlled ... to minimize pain. The versatile design of the ... hand coverage. ,For added support, support bars are ... if a wider range of motion is desired.,All ...
... and Cronin, Inc. is ... Patient Footwear, Orthopedic Softgoods, ... Products. Our products are ... and available in the ...
... Cubital Tunnel Splint immobilizes and positions the ... nerve is less prominent. Restricts full extension ... ulnar nerve, and helps prevent pain and ... nerve transposition and post-cast removal. Rigid, high-density ...
Medicine Products:
(Date:7/10/2020)... ... ... The Urgent Care Association (UCA), College of Urgent Care Medicine (CUCM) and ... education on acute flaccid myelitis (AFM), an uncommon but serious condition that most commonly ... 14, 2020. , AFM, which is most prevalent in children, is a rapidly ...
(Date:7/7/2020)... BELOIT, Wis. (PRWEB) , ... July 07, 2020 , ... ... Impact Fund for Global PH Research Award at its first ever virtual research town ... PH along with clinical experts will showcase the latest research in the area of ...
(Date:7/7/2020)... ... July 07, 2020 , ... SupplyPro announces a Contact ... of COVID-19 is affecting every one of us. SupplyPro is dedicated to supporting the ... run a Contact Tracing Report - a powerful tool in the fight against the ...
Breaking Medicine Technology:
... 24, 2011 Auxilium Pharmaceuticals, Inc. (Nasdaq: ... in the Stifel Nicolaus 2011 Healthcare Conference during September ...  Mr. Jim Fickenscher, Chief Financial Officer, is scheduled to ... pipeline at 11:30 am ET on Wednesday, September 7, ...
... Aug. 23, 2011 TRX, Inc. ( www.trx.com ... technology, process automation, consulting and data services, announced ... to several leading companies in the pharmaceutical, technology, ... ways to manage their travel and procurement reporting ...
Cached Medicine Technology: